The boost in bottomline was also on account of low base in year-ago period. The company had reported an exceptional loss of Rs 685.2 crore in Q1FY16 on account of integration and optimisation measures post Ranbaxy acquisition.
first published: Aug 12, 2016 02:07 pm
A collection of the most-viewed Moneycontrol videos.

Live: Nifty extends gain to the second straight day but sees another weekly loss | Closing Bell

Live: Can Nifty extend gains and reclaim 26,000? | Opening Bell
FSS Simply Payments 2025 | AI in Payments: Building a Governance-First Future.

Live: Nifty reclaims 25,900, snaps 3-day losing streak; rupee falls to fresh low | Closing Bell
You are already a Moneycontrol Pro user.


